Bypass versus endovascular treatment for long superficial femoral artery lesions causing claudication
Official title: Bypass Versus Endovascular Procedure in Long Lesions of the Superficial Femoral Artery in the Claudicant
Run by Assistance Publique - Hôpitaux de Paris · NCT05216731 · Data updated 2026-11-12
This trial tests whether femoro-popliteal bypass surgery or an endovascular procedure better keeps 15–25 cm superficial femoral artery blockages open in adults with moderate leg claudication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 290 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 16 sites (Bordeaux and 15 other locations) |
| Status | Recruiting |
| Started | January 20, 2025 |
| Main results expected | March 7, 2030 |
| Study ends | May 20, 2030 |
| Registry record updated | October 3, 2025 |
| Trial ID | NCT05216731 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with unilateral Rutherford 2 or 3 lower extremity arterial disease due to a 15–25 cm TASC C or D lesion of the superficial femoral artery who are eligible for both bypass surgery and endovascular treatment are ideal candidates.
✕Probably not a fit
Patients with altered iliac inflow, prior surgery or stent on the affected superficial femoral artery, active bacteremia, pregnancy, breastfeeding, or contraindications to antiplatelet therapy or heparin are unlikely to be eligible or benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study directly compares surgical femoro-popliteal bypass with endovascular treatment for long (15–25 cm) lesions of the superficial femoral artery in patients with unilateral Rutherford 2–3 claudication. Eligible patients must be suitable for both procedures and have preserved or restored iliac inflow with at least one patent below-knee artery. Participants will undergo the assigned revascularization and be followed for vessel patency, symptom relief, and complications over planned follow-up visits. The aim is to generate prospective head-to-head data to inform treatment choice for long femoro-popliteal lesions.
Why it matters
Potential benefit: If successful, the trial could identify which procedure provides longer-lasting artery patency and better walking ability, helping doctors choose the best first-line treatment.
How similar studies have gone: There is no dedicated randomized head-to-head trial for these long lesions; retrospective series suggest endovascular patency may be lower than surgery but definitive prospective comparisons are lacking.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient * Effective contraception for the duration of research for fertile women of childbearing age * Unilateral Rutherford 2 or 3 symptomatic Lower Extremity Artery Disease (LEAD) arteritic patient with a lesion of the superficial femoral artery Trans-Atlantic Inter-Society Consensus (TASC) C or D between 15 and 25 cm * Patient eligible for bypass surgery and endovascular procedure * No alteration of the upstream flow (iliac flow preserved or restored) * Patient with at least one patent artery below the knee * Patient informed and having signed the information and consent form to participate in the study Exclusion Criteria: * Known pregnancy or breastfeeding * Iliac flow altered upstream * History of surgery or stent on the affected superficial femoral artery * Concomitant bacteremia (positive blood cultures in the 7 days preceding the procedure) * Known intolerance to antiaggregants or heparin * Contraindication to the endovascular procedure (severe renal failure contraindicating the injection of contrast product despite prior hydration, known severe allergy to iodinated contrast product \[unless the center chooses to use carbon dioxide injection\]) or bypass surgery (cardiovascular, respiratory or other comorbidities, contraindicating general anesthesia, local contraindications for bypass: skin lesion at the operative site) * No affiliation to a social security regime or to another social protection regime * Patient deprived of liberty or under legal protection (guardianship, trusteeship) * Inability, according to the investigator, to understand or refusal to sign the informed consent to participate in the study (non-French speaking patient, cognitive disorders) * Ongoing participation in another research protocol Participation in non-interventional research is authorized Secondary exclusion criterion: * Negative opinion from the anesthesiologist-resuscitator at the end of the pre-anesthetic consultation * Positive pregnancy test from the pre-operative laboratory test (result received after obtaining consent, but before the surgical procedure)
Where it's running
-
Hôpital Henri Mondor, APHP
Créteil, France Recruiting -
Hôpital François Mitterrand
Dijon, France Recruiting -
CHU de Poitiers
Poitiers, France Recruiting -
CHU - Hôpitaux de Bordeaux
Bordeaux, France Active not recruiting -
Hôpital Ambroise Paré, APHP
Boulogne-Billancourt, France Active not recruiting -
Hôpital de la Cavale Blanche
Brest, France Active not recruiting
Show 10 more locations
-
Centre hospitalier René Dubos
Cergy-Pontoise, France Active not recruiting -
Hôpital Edouard Herriot
Lyon, France Active not recruiting -
Hôpital de la Timone, APHP
Marseille, France Not yet recruiting -
CHU de Nice
Nice, France Active not recruiting -
CHU Carémeau
Nîmes, France Not yet recruiting -
Hôpital Européen Georges Pompidou, APHP
Paris, France Active not recruiting -
Hôpital Bichat - Claude Bernard, APHP
Paris, France Active not recruiting -
Hôpital La Pitié-Salpêtrière, APHP
Paris, France Not yet recruiting -
CHU de Rangueil
Toulouse, France Active not recruiting -
Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu
Vandœuvre-lès-Nancy, France Not yet recruiting
Study contacts
- Study coordinator: Joseph TOUMA, MD, PhD
- Email: joseph.touma@aphp.fr
- Phone: + 33 6 30 03 10 93
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treatment for various skin conditions using AVAVA technology
This study is testing a new device called AVAVA to see if it can help improve skin problems like acne, scars, and wrinkles.
-
Evaluating masseter muscle thickness after nerve treatment for trigeminal neuralgia
This study is testing whether a specific nerve treatment for trigeminal neuralgia can change the thickness of the masseter muscle in patients who haven't found relief from other medications.
-
Surgical treatment for gum tissue issues after removing localized growths
This study is testing a new surgical method to help people with gum problems after removing growths, aiming to improve their gum health and reduce complications.
-
Measuring brain stimulation effects on hand strength in brain tumor patients
This study tests if brain stimulation during surgery can improve hand strength and function in patients with brain tumors affecting the part of the brain that controls movement.
-
Surgical approach for treating advanced gum disease with grafting
This study is testing a new surgical technique for people with advanced gum disease to see if it helps their gums heal better and improves their overall dental health.
-
Collarless Actis hip stem for cementless hip replacement in Asian patients
This study tests how well a collarless Actis hip stem works in adults undergoing primary hip replacement, focusing on outcomes over five years in an East Asian population.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.